Final Overall Survival Analysis Of The Tbp Phase Ill Study (Gbg 26/Big 3-05): Capecitabine Vs. Capecitabine Plus Trastuzumab In Patients With Her2-Positive Metastatic Breast Cancer Progressing During Trastuzumab Treatment

CANCER RESEARCH(2010)

引用 0|浏览24
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要